Vitamin D(3) and deconvoluting a rash

BACKGROUND: Adverse drug reactions are unpredictable immunologic events presenting frequent challenges to clinical management. Systemically administered cholecalciferol (vitamin D(3)) has immunomodulatory properties. In this randomized, double-blinded, placebo-controlled interventional trial of heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Ernst, Madison K., Evans, Spencer T., Techner, Jose-Marc, Rothbaum, Robert M., Christensen, Luisa F., Onay, Ummiye Venus, Biyashev, Dauren, Demczuk, Michael M., Nguyen, Cuong V., Honda, Kord S., McCormick, Thomas S., Tsoi, Lam C., Gudjonsson, Johann E., Cooper, Kevin D., Lu, Kurt Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977299/
https://www.ncbi.nlm.nih.gov/pubmed/36692020
http://dx.doi.org/10.1172/jci.insight.163789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977299/
https://www.ncbi.nlm.nih.gov/pubmed/36692020
http://dx.doi.org/10.1172/jci.insight.163789

Ejemplares similares